Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

ARAY


Top 10 Correlated ETFs

ARAY


Top 10 Correlated Stocks

ARAY


In the News

01:33 04 Oct 2022 ARAY

3 Reasons to Hold Accuray (ARAY) Stock in Your Portfolio

Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.

02:18 04 Oct 2022 ARAY

Accuray's (ARAY) Latest Collaboration to Improve Patient Care

Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.

02:18 04 Oct 2022 ARAY

Accuray (ARAY) Q4 Earnings Beat Estimates, Margins Down

Despite solid Product revenues, Accuray (ARAY) reports an overall soft Q4 performance.

08:35 04 Oct 2022 ARAY

Accuray Incorporated (ARAY) CEO Suzanne Winter on Q4 2022 Results - Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY ) Q4 2022 Results Conference Call August 10, 2022 4:30 PM ET Company Participants Ken Mobeck - Vice President-Finance Suzanne Winter - President & Chief Executive Officer Ali Pervaiz - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Neil Chatterji - B. Riley Marie Thibault - BTIG Josh Jennings - Cowen Jason Wittes - Loop Capital Operator Good afternoon, and welcome to the Accuray Fourth Quarter 2022 Financial Results Conference Call.

07:33 04 Oct 2022 ARAY

Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates

Accuray (ARAY) delivered earnings and revenue surprises of 33.33% and 4.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

01:05 04 Oct 2022 ARAY

3 Reasons to Add Accuray (ARAY) Stock to Your Portfolio Now

Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.

12:47 04 Oct 2022 ARAY

Here's Why You Should Hold on to Accuray (ARAY) Stock For Now

Investors continue to be optimistic about Accuray (ARAY) owing to its solid global reach.

10:32 04 Oct 2022 ARAY

Accuray's (ARAY) New Tie-Up to Augment Treatment Planning

Accuray (ARAY) partners with Limbus AI to enhance the treatment planning process and patient care.

11:23 04 Oct 2022 ARAY

Down 20% in 4 Weeks, Here's Why Accuray (ARAY) Looks Ripe for a Turnaround

Accuray (ARAY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

12:02 04 Oct 2022 ARAY

Accuray (ARAY) Q3 Earnings Beat Estimates, Revenues Lag

Despite strong product demand, Accuray (ARAY) reports an overall soft Q3 performance.

Financial details

Company Rating
Buy
Market Cap
194.48M
Income
-5.35M
Revenue
429.91M
Book val./share
0.58
Cash/share
0.96
Dividend
-
Dividend %
-
Employees
1.04K
Optionable
No
Shortable
Yes
Earnings
01 Nov 2022
P/E
-35.83
Forward P/E
-9.5
PEG
17.98
P/S
0.45
P/B
3.6
P/C
2.28
P/FCF
-26.92
Quick Ratio
0.88
Current Ratio
1.68
Debt / Equity
3.43
LT Debt / Equity
3.43
-
-
EPS (TTM)
-0.06
EPS next Y
-0.23
EPS next Q
-0.07
EPS this Y
-17.14%
EPS next Y
310.36%
EPS next 5Y
310.36%
EPS last 5Y
-27.01%
Revenue last 5Y
1.21%
Revenue Q/Q
14.41%
EPS Q/Q
236.36%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
66.48%
Inst Trans
-7.87%
ROA
-1%
ROE
-11%
ROC
0.03%
Gross Margin
37%
Oper. Margin
2%
Profit Margin
-1%
Payout
-
Shs Outstand
93.5M
Shs Float
84.58M
-
-
-
-
Target Price
7
52W Range
1.7-5.93
52W High
-56.3%
52W Low
+118.5%
RSI
42
Rel Volume
0.65
Avg Volume
547.47K
Volume
355.45K
Perf Week
2.58%
Perf Month
-22.52%
Perf Quarter
-31.5%
Perf Half Y
-35.36%
-
-
-
-
Beta
1.7495
-
-
Volatility
0.06%, 0.19%
Prev Close
5.05%
Price
2.185
Change
6.59%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-06-30

Metric History 2018-06-302019-06-302020-06-302021-06-30 2022-06-30
Revenue per share
4.774.794.264.314.67
Net income per share
-0.28-0.190.04-0.07-0.06
Operating cash flow per share
0.22-0.34-0.020.42-0.03
Free cash flow per share
0.14-0.39-0.060.39-0.08
Cash per share
0.980.881.21.260.96
Book value per share
0.570.570.710.750.58
Tangible book value per share
-0.12-0.10.060.11-0.05
Share holders equity per share
0.570.570.710.750.58
Interest debt per share
1.7222.42.352.17
Market cap
318.35M359.48M204.01M377.33M193.4M
Enterprise value
366.34M442.53M293.97M460.37M304.15M
P/E ratio
-13.32-21.8853.31-59.79-36.17
Price to sales ratio
0.790.860.530.950.45
POCF ratio
17.37-12.13-138.889.8-80.58
PFCF ratio
27.16-10.59-39.2610.43-27.17
P/B Ratio
6.557.213.215.483.64
PTB ratio
6.557.213.215.483.64
EV to sales
0.91.060.771.160.71
Enterprise value over EBITDA
219.3739.49.3924.5986.63
EV to operating cash flow
19.98-14.93-200.1111.95-126.73
EV to free cash flow
31.25-13.03-56.5612.72-42.74
Earnings yield
-0.08-0.050.02-0.02-0.03
Free cash flow yield
0.04-0.09-0.030.1-0.04
Debt to equity
2.73.212.972.723.43
Debt to assets
0.870.890.870.860.89
Net debt to EBITDA
28.747.392.874.4431.54
Current ratio
1.681.791.961.831.68
Interest coverage
-0.250.040.691.320
Income quality
-0.771.8-0.38-6.10.45
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.120.120.10.110.1
Research and developement to revenue
0.140.130.130.130.13
Intangibles to total assets
0.150.130.120.120.12
Capex to operating cash flow
-0.360.152.54-0.061.97
Capex to revenue
-0.02-0.01-0.01-0.01-0.01
Capex to depreciation
-0.68-0.41-0.49-0.36-0.86
Stock based compensation to revenue
0.030.030.020.020.02
Graham number
1.91.550.821.070.87
ROIC
-0.0200.040.080.03
Return on tangible assets
-0.07-0.040.01-0.01-0.01
Graham Net
-1.69-1.91-2.05-1.82-2.05
Working capital
114.72M151.89M175.22M160.41M142.03M
Tangible asset value
-10.04M-8.58M5.26M10.45M-4.9M
Net current asset value
-45.94M-44.24M-69.81M-58.49M-68.77M
Invested capital
2.73.213.12.93.75
Average receivables
75.68M98.62M87.98M85.36M89.9M
Average payables
19.58M24.51M21.3M19.47M25.4M
Average inventory
117.23M123.38M130.15M125.93M134.09M
Days sales outstanding
59.4997.5286.3678.6280.18
Days payables outstanding
29.5642.1336.230.0142.37
Days of inventory on hand
162.9172.18210.31194.12192.34
Receivables turnover
6.143.744.234.644.55
Payables turnover
12.358.6610.0812.168.61
Inventory turnover
2.242.121.741.881.9
ROE
-0.49-0.330.06-0.09-0.1
Capex per share
-0.08-0.05-0.04-0.03-0.05

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q4

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
1.211.181.271.051.19
Net income per share
-0.12-0.010-0.01-0.04
Operating cash flow per share
0.07-0.090.36-0.24-0.05
Free cash flow per share
0.06-0.110.35-0.25-0.07
Cash per share
1.271.151.341.070.96
Book value per share
0.750.50.560.560.58
Tangible book value per share
0.11-0.14-0.08-0.07-0.05
Share holders equity per share
0.750.50.560.560.58
Interest debt per share
2.182.442.222.22.17
Market cap
414.09M358.81M437.7M303.73M180.51M
Enterprise value
497.13M476.09M518.62M407.42M291.26M
P/E ratio
-9.33-87.26611.31-72.59-13.07
Price to sales ratio
3.733.343.763.161.64
POCF ratio
66.84-41.7213.42-13.95-38.87
PFCF ratio
78.1-35.6813.76-13.3-29.89
P/B Ratio
6.027.848.585.893.39
PTB ratio
6.027.848.585.893.39
EV to sales
4.484.434.464.242.65
Enterprise value over EBITDA
-54.07579.18249.22533.27-1.87K
EV to operating cash flow
80.25-55.3615.9-18.72-62.72
EV to free cash flow
93.76-47.3416.3-17.85-48.22
Earnings yield
-0.03000-0.02
Free cash flow yield
0.01-0.030.07-0.08-0.03
Debt to equity
2.724.593.693.593.43
Debt to assets
0.860.90.890.890.89
Net debt to EBITDA
-9.03142.6838.89135.72-709.96
Current ratio
1.831.861.721.721.68
Interest coverage
00000
Income quality
-0.568.37182.1820.811.35
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.10.110.090.110.11
Research and developement to revenue
0.140.130.130.150.13
Intangibles to total assets
0.120.120.120.120.12
Capex to operating cash flow
-0.140.17-0.020.050.3
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.6-1.03-0.56-0.76-1.1
Stock based compensation to revenue
0.020.020.020.030.02
Graham number
1.430.360.160.380.7
ROIC
0.010.010.0100.01
Return on tangible assets
-0.03000-0.01
Graham Net
-1.83-2.11-1.94-2.01-2.05
Working capital
160.41M162.2M146.93M145.86M142.03M
Tangible asset value
10.45M-12.56M-7.33M-6.68M-4.9M
Net current asset value
-58.49M-79.49M-73.19M-70.63M-68.77M
Invested capital
2.94.8543.93.75
Average receivables
87.33M91.67M85.6M89.3M91.87M
Average payables
25.92M27.47M30.81M32.36M31.85M
Average inventory
131.72M132.01M130.6M137.52M139.89M
Days sales outstanding
69.2578.7763.483.5777.25
Days payables outstanding
26.0729.9135.7547.4542.09
Days of inventory on hand
168.64167.62151.14201.62191.08
Receivables turnover
1.31.141.421.081.16
Payables turnover
3.453.012.521.92.14
Inventory turnover
0.530.540.60.450.47
ROE
-0.16-0.020-0.02-0.06
Capex per share
-0.01-0.02-0.01-0.01-0.02

Frequently Asked Questions

What is Accuray Incorporated stock symbol ?

Accuray Incorporated is a US stock , located in Sunnyvale of California and trading under the symbol ARAY

Is Accuray Incorporated buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $7. The lowest prediction is $7 and the highest is $7

What is ARAY stock prediction ?